More articles from Clinical

You have access
Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer: Results from a Prospective Imaging Trial
Nils H. Nicolay, Alexander Rühle, Nicole Wiedenmann, Gabriele Niedermann, Michael Mix, Wolfgang A. Weber, Dimos Baltas, Martin Werner, Gian Kayser and Anca-L. Grosu

Journal of Nuclear Medicine April 1, 2021, 62 (4) 471-478; DOI: https://doi.org/10.2967/jnumed.120.248633
You have access
Surveillance of Clinically Complete Responders Using Serial ¹⁸F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy
Maria J. Valkema, Berend J. van der Wilk, Ben M. Eyck, Bas P.L. Wijnhoven, Manon C.W. Spaander, Michail Doukas, Sjoerd M. Lagarde, Wendy M.J. Schreurs, Mark J. Roef, J. Jan B. van Lanschot and Roelf Valkema

Journal of Nuclear Medicine April 1, 2021, 62 (4) 486-492; DOI: https://doi.org/10.2967/jnumed.120.247981
You have access
A Microdosing Study with ^99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients
Oana C. Kulterer, Sarah Pfaff, Wolfgang Wadsak, Nathalie Garstka, Mesut Remzi, Chrysoula Vraka, Lukas Nics, Markus Mitterhauser, Franziska Bootz, Samuele Cazzamalli, Nikolaus Krall, Dario Neri and Alexander R. Haug

Journal of Nuclear Medicine March 1, 2021, 62 (3) 360-365; DOI: https://doi.org/10.2967/jnumed.120.245530
You have access
Fluorescence-Guided Visualization of Soft-Tissue Sarcomas by Targeting Vascular Endothelial Growth Factor A: A Phase 1 Single-Center Clinical Trial
Pieter J. Steinkamp, Bobby K. Pranger, Mei-Fang Li, Matthijs D. Linssen, Floris J. Voskuil, Lukas B. Been, Barbara L. van Leeuwen, Albert J.H. Suurmeijer, Wouter B. Nagengast, Schelto Kruijff, Robert J. van Ginkel and Gooitzen M. van Dam

Journal of Nuclear Medicine March 1, 2021, 62 (3) 342-347; DOI: https://doi.org/10.2967/jnumed.120.245696
You have access
Diagnostic Performance of Pulmonary Embolism Imaging in Patients with History of Asthma
Matthew S. Lazarus, Yoel Kim, Bertin Mathai, Jeffrey M. Levsky, Leonard M. Freeman, Linda B. Haramati and Renee M. Moadel

Journal of Nuclear Medicine March 1, 2021, 62 (3) 399-404; DOI: https://doi.org/10.2967/jnumed.120.242776
You have access
Head-to-Head Evaluation of ¹⁸F-FES and ¹⁸F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer
Gary A. Ulaner, Komal Jhaveri, Sarat Chandarlapaty, Vaios Hatzoglou, Christopher C. Riedl, Jason S. Lewis and Audrey Mauguen

Journal of Nuclear Medicine March 1, 2021, 62 (3) 326-331; DOI: https://doi.org/10.2967/jnumed.120.247882
You have access
Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of ¹⁷⁷Lu-DOTA-EB-TATE
Qingxing Liu, Jie Zang, Huimin Sui, Jiakun Ren, Hua Guo, Hao Wang, Rongxi Wang, Orit Jacobson, Jingjing Zhang, Yuejuan Cheng, Zhaohui Zhu and Xiaoyuan Chen

Journal of Nuclear Medicine March 1, 2021, 62 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.120.248658
You have access
Nondisplaceable Binding Is a Potential Confounding Factor in ¹¹C-PBR28 Translocator Protein PET Studies
Gjertrud L. Laurell, Pontus Plavén-Sigray, Aurelija Jucaite, Andrea Varrone, Kelly P. Cosgrove, Claus Svarer, Gitte M. Knudsen, Karolinska Schizophrenia Project Consortium, R. Todd Ogden, Francesca Zanderigo, Simon Cervenka, Ansel T. Hillmer and Martin Schain

Journal of Nuclear Medicine March 1, 2021, 62 (3) 412-417; DOI: https://doi.org/10.2967/jnumed.120.243717
You have access
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease
Regine Kluge, Tim Wittig, Thomas W. Georgi, Lars Kurch, Osama Sabri, W. Hamish Wallace, Tomasz Klekawka, Ana Fernández-Teijeiro, Francesco Ceppi, Jonas Karlén, Jane Pears, Michaela Cepelová, Alexander Fosså, Auke Beishuizen, Lisa Lyngsie Hjalgrim, Dieter Körholz, Christine Mauz-Körholz and Dirk Hasenclever

Journal of Nuclear Medicine March 1, 2021, 62 (3) 338-341; DOI: https://doi.org/10.2967/jnumed.120.247924
You have access
Dissimilar DNA Damage to Blood Lymphocytes After ¹⁷⁷Lu-Labeled DOTATOC or Prostate-Specific Membrane Antigen Therapy
Philipp Ritt, Camille Jobic, Michael Beck, Christian Schmidkonz, Torsten Kuwert, Michael Uder and Michael Brand

Journal of Nuclear Medicine March 1, 2021, 62 (3) 379-385; DOI: https://doi.org/10.2967/jnumed.120.243782

Main menu

User menu

Search

More articles from Clinical

Pages